H2L 5765834

CAS No. 420841-84-5

H2L 5765834( —— )

Catalog No. M24386 CAS No. 420841-84-5

H2L 5765834 is a lysophosphatidic acid receptors antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 126 In Stock
5MG 116 In Stock
10MG 187 In Stock
25MG 353 In Stock
50MG 514 In Stock
100MG 732 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    H2L 5765834
  • Note
    Research use only, not for human use.
  • Brief Description
    H2L 5765834 is a lysophosphatidic acid receptors antagonist.
  • Description
    H2L 5765834 is a lysophosphatidic acid receptors antagonist.
  • In Vitro
    H2L 5765834 displays no effect on LPA2 or LPA4 receptors.H2L 5765834 inhibits LPA-induced platelet shape change with an IC50 of 13.73±2.52 μM.
  • In Vivo
    H2L 5765834 (20 mg/kg; i.p.) could not affect the LPA-induced decrease of alanine transaminase (ALT) in the acetaminophen (APAP) overdose-induced acute liver injury model.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    LPA Receptor
  • Recptor
    lysophosphatidic acid receptors
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    420841-84-5
  • Formula Weight
    404.33
  • Molecular Formula
    C21H12N2O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:40mg/ml(98.93mM; need ultrasonic)
  • SMILES
    [O-][N+](c(cc1)ccc1Oc1cc(N(C(c(cc2)c3cc2C(O)=O)=O)C3=O)ccc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • H2L5186303

    H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment.

  • BMS-986278

    BMS-986278 is an orally active and potent hemophosphatidic acid receptor 1 (LPA1) antagonist with Kb values of 6.9 nM and 4.0 nM for human and mouse LPA1, respectively.

  • 1-Oleoyl lysophospha...

    1-Oleoyl lysophosphatidic acid sodium salt is an Endogenous agonist of LPA1 and LPA2.